Dutch College of General Practitioner's practice guidelines on type 2 diabetes mellitus, hypertension and asthma in adults, contain less ethnic knowledge than the supporting literature;Minder etnische kennis in de standaarden van het Nederlands Huisartsen Genootschap over diabetes mellitus type 2, hypertensie en over astma bij volwassenen dan in de onderbouwende literatuur

Nederlands Tijdschrift voor Geneeskunde

Volumn 147, Issue 35, 2003, Pages 1691-1696

  Manna, D R ^a   Bruijnzeels, M A ^a   Mokkink, H G A ^b   Berg, M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ASTHMA; DISEASE COURSE; EARLY DIAGNOSIS; ETHNIC DIFFERENCE; ETHNIC GROUP; GENERAL PRACTITIONER; GEOGRAPHIC DISTRIBUTION; HEALTH CARE QUALITY; HUMAN; HYPERTENSION; LUNG VOLUME; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; MEDICAL LITERATURE; MINORITY GROUP; NETHERLANDS; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RISK; PRACTICE GUIDELINE; PREVALENCE; REVIEW; SODIUM RESTRICTION;

ASTHMA; DIABETES MELLITUS, TYPE 2; ETHNIC GROUPS; HUMANS; HYPERTENSION; META-ANALYSIS; NETHERLANDS; PHYSICIANS, FAMILY; PRACTICE GUIDELINES; PREVALENCE;

EID: 0043132402     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. Sociaal en Cultureel Planbureau (SCP). Sociaal en Cultureel Rapport 1998. Rijswijk: SCP; 1998.
2. Materson BJ, Reda DJ, Cushman WC, Massie BM, Freis ED, Kochar MS, et al. Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. N Engl J Med 1993;328:914-21.
3. Bruijnzeels M. De multiculturele huisartsenpraktijk. Migrantenstudies 2001;17:72-84.
4. Manna DR, Bootsma AH, Lamberts SWJ, Mackenbach JP. Samenhang tussen etniciteit en verwijsreden bij nieuwe patiënten op de polikliniek Inwendige Geneeskunde van het Academisch Ziekenhuis Rotterdam-Dijkzigt, 1997. Ned Tijdschr Geneeskd 2000;144:1785-9.
5. Wieringen JCM van, Harmsen JAM, Bruijnzeels MA. Intercultural communication in general practice. Eur J Public Health 2002;12:63-8.
6. Rutten GEHM, Thomas S. NHG-standaarden voor de huisarts. Utrecht: Bunge; 1993.
7. Manna DR, Bruijnzeets MA, Mokkink HGA, Berg M. Ethnic specific recommendations in clinical practice guidelines. An international comparison. Quality and Safety in Health Care [ter perse].
8. Rutten GEHM, Verhoeven S, Heine RJ, Grauw WJC de, Cromme PVM, Reenders K, et al. NHG-standaard Diabetes mellitus type 2 (eerste herziening). Huisarts Wet 1999;42:67-84.
9. Walma EP, Grundmeijer HGLM, Thomas S, Prins A, Hoogen JPH van den, Laan JR van der. NHG-standaard Hypertensie (eerste herziening). Huisarts Wet 1997;40:598-617.
10. Geijger RMM, Thiadens HA, Smeele IJM, Sachs APE, Bottema BJAM, Hensbergen W van, et al. NHG-standaard COPD en astma bij volwassenen: diagnostiek. Huisarts Wet 2001;44:107-17.
11. Geijger RMM, Hensbergen W van, Bottema BJAM, Schayck CP van, Sachs APE, Smeele IJM, et al. NHG-standaard Astma bij volwassenen: behandeling. Huisarts Wet 2001;44:153-64.
12. Bongers I, Westendorp RGJ, Stolk B, Huysmans HA, Vandenbroucke JP. Vroegtijdige coronaire hartziekten samengaand met diabetes mellitus type II bij personen van Hindoestaanse afkomst. Ned Tijdschr Geneeskd 1995;139:16-8.
13. Querido J. De prevalentie van diabetes mellitus type II in een achterstandsbuurt. Huisarts Wet 1995;38:250-4.
14. Berghout A, Dijkstra S. Diabetes mellitus type II bij Hindoestanen; nieuwe verschijningsvormen van oude ziektebeelden. Ned Tijdschr Geneeskd 1995;139:3-7.
15. Bailey CJ, Turner RC. Metformin. N Engl J Med 1996;334:574-9.
16. Krentz AJ. Insulin resistance. BMJ 1996;313:1385-9.
17. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183-97.
18. Finch C, Zimmet P. Mortality from diabetes. Diabetes Annual 1988;4:1-14.
19. Greenhalgh P. Shared care for diabetes. A systematic review. Occasional paper 67. Londen: Royal College of General Practitioners; 1994.
20. Zimmet P. Type 2 (non-insulin-dependent) diabetes - an epidemiological overview. Diabetologia 1982;22:399-411.
21. Wilson PW, Anderson KM, Kannel WB. Epidemiology of diabetes mellitus in the elderly. Am J Med 1986;80 Suppl 5A:3-9.
22. Alzaid AA. Microalbuminuria in patients with NIDDM: an overview. Diabetes Care 1996;19:79-89.
23. Gilbert RE, Cooper ME, McNally PG, O'Brien RC, Taft J, Jerums G. Microalbuminuria: prognostic and therapeutic implications in diabetes mellitus. Diabet Med 1994;11:636-45.
24. Stehouwer CDA, Jager A, Donker AJM. Microalbuminurie bij essentiële hypertensie: van beperkte betekenis voor het aanwijzen van patiënten met een hoog risico voor complicaties. Ned Tijdschr Geneeskd 1997;141:1649-53.
25. American Diabetes Association. Consensus statement. Self-monitoring of blood glucose. Diabetes Care 1994;17:81-6.
26. Reiber GE. The epidemiology of diabetic foot problems. Diabet Med 1996;13 Suppl 1:S6-11.
27. Anastos K, Charney P, Charon RA, Cohen E, Jones CY, Marte C, et al. Hypertension in women: what is really known? The Women's Caucus, Working Group on Women's Health of the Society of General Internal Medicine. Ann Intern Med 1991;115:287-93.
28. Bennet NE. Hypertension in the elderly. Lancet 1994;344:447-9.
29. Havlik RJ, Hubert HB, Fabsitz RR, Feinleib M. Weight and hypertension. Ann Intern Med 1983;98(5 Pt 2):855-9.
30. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993;153:154-83.
31. Ogilvie RI, Burgess ED, Cusson JR, Feldman RD, Leiter LA, Myers MG. Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of essential hypertension. CMAJ 1993;149:575-84.
32. Freis ED, Reda DJ, Materson BJ. Volume (weight) loss and blood pressure response following thiazide diuretics. Hypertension 1988;12:244-50.
33. Veterans Administration Cooperative Study Group on Antihypertensive agents. Comparison of propranolol and hydrochlorothiazide for the initial treatment of hypertension. I. Results of short-term titration with emphasis on racial differences in response. JAMA 1982;248:1996-2003.
34. Who needs nine ACE inhibitors? Drug Ther Bull 1995;33:1-3.
35. Cutler JA. Combinations of lifestyle modification and drug treatment in management of mild-moderate hypertension: a review of randomized clinical trials. Clin Exp Hypertens 1993;15:1193-204.
36. Graeff PA de, Gilst WH van. ACE-remmers. Geneesmiddelenbulletin 1991;25:37-41.
37. Resnick LM. Cellular calcium and magnesium metabolism in the pathofysiology and treatment of hypertension and related metabolic disorders. Am J Med 1993;93:105-205.
38. Swales JD. Pharmacological treatment of hypertension. Lancet 1994;344:380-5.
39. Alderman MH. Non-pharmacological treatment of hypertension. Lancet 1994;344:307-11.
40. Haynes RB, Lacourciere Y, Rabkin SW, Leenen FH, Logan AG, Wright N, et al. Report of the Canadian Hypertension Society Consensus Conference: 2. Diagnosis of hypertension in adults. CMAJ 1993;149:409-18.
41. Morales PA, Mitchell BD, Valdez RA, Hazuda HP, Stem MP, Haffner SM. Incidence of NIDDM and impaired glucose tolerance in hypertensive subjects. Diabetes 1993;42:154-61.
42. Rosner B, Polk BF. Predictive values of routine blood pressure measurements in screening for hypertension. Am J Epidemiol 1983;117:429-42.
43. Standardized lung function testing. Report working party. Bull Eur Physiopathol Respir 1983;19 Suppl 5:1-95.
44. Global strategy for asthma management and prevention. NHLBI/WHO report. National Institutes of Health. Bethesda, Md.: National Heart, Lung, and Blood Institute; 1995.
45. Bottema B. Diagnostiek van CARA in de huisartspraktijk [proefschrift]. Amsterdam: Universiteit van Amsterdam; 1993.
46. Commissie Diagnostiek astma bronchiale en COPD, NVALT. Standaard diagnostiek van astma bronchiale en COPD. Pulmoscript 1994;3:31-46.
47. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J 1993;16 Suppl:5-40.
48. Sorgdrager B, Pal TM, Lende R van der. Literatuurstudie naar beroepsmatige expositie en bronchiale hyperreactiviteit. Leusden: Nederlands Astma Fonds; 1988.
49. Lang DM, Polansky M. Patterns of asthma mortality in Philadelphia from 1969 to 1991. N Engl J Med 1994;331:1542-6.
50. Wiersma T. Overwegingen bij de NHG-standaard Cholesterol. Huisarts Wet 1992;35:97-100.
51. Berg M, Klazinga N, Hout B van. Goede zorg is niet altijd passende zorg. Van evidence-based naar value-based. Med Contact 1999;54:1040-3.
52. Leape LL, Park RE, Kahan JP, Brook RH. Group judgments of appropriateness: the effect of panel composition. Qual Assur Health Care 1992;4:151-9.